MedPath

Pilot study on the use of a radiopaque hydrogel during breast conserving surgery with full-thickness closure for target definition and positioning of boost or partial breast irradiation.

Phase 2
Completed
Conditions
breast cancer
breast carcinoma
10006291
10006295
Registration Number
NL-OMON47859
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

* Woman
* Undergoing breast conserving surgery
* Indication for radiotherapy
* Full thickness closure (level 1 oncoplastic breast surgery) planned
* Written informed consent

Exclusion Criteria

* Oncoplasty technique (level 2 Oncoplastic breast surgery) planned
* need for adjuvant chemotherapy
* Allergy for PEG
* Allergy for Iodine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>primary endpoint: the Conformity Index (Cx) of target definition.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints: the distance between observers* target volumes (dCOM),<br /><br>target volumes, Cavity Visualisation Score, feasibility of the hydrogel marker<br /><br>instillation, stability of the hydrogel marker volume over time, adverse<br /><br>events, ease of use, motion of hydrogel marker/clips over time, the feasibility<br /><br>of patient positioning based on the hydrogel marker on cone beam computed<br /><br>tomography (CBCT) and planar kV images made on a conventional linac and a<br /><br>Cyberknife and the accuracy of this procedure compared to positioning based on<br /><br>the surgical clips.</p><br>
© Copyright 2025. All Rights Reserved by MedPath